A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept
ImmunoHorizons · 2023
DOI: 10.4049/immunohorizons.2300031 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift ImmunoHorizons, 2023. Verfasst von Edwin J Ostrin und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans, Lung Transplantation, Graft vs Host Disease, Bronchiolitis Obliterans Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Respiratory inflammation in bronchiolitis obliterans syndrome (BOS) after hematopoietic cell transplantation (HCT) is poorly understood. Clinical criteria for early-stage BOS (stage 0p) often capture HCT recipients without BOS. Measuring respiratory tract inflammation may help identify BOS, particularly early BOS. We conducted a prospective observational study in HCT recipients with new-onset BOS (n = 14), BOS stage 0p (n = 10), and recipients without lung impairment with (n = 3) or without (n = 8) chronic graft-versus-host disease and measured nasal inflammation using nasosorption at enrollment and then every 3 mo for 1 y. We divided BOS stage 0p into impairment that did not return to baseline values (preBOS, n = 6), or transient impairment (n = 4). We tested eluted nasal mucosal lining fluid from nasosorption matrices for inflammatory chemokines and cytokines using multiplex magnetic bead immunoassays. We analyzed between-group differences using the Kruskal–Wallis method, adjusting for multiple comparisons. We found increased nasal inflammation in preBOS and therefore directly compared patients with preBOS to those with transient impairment, as this would be of greatest diagnostic relevance. After adjusting for multiple corrections, we found significant increases in growth factors (FGF2, TGF-α, GM-CSF, VEGF), macrophage activation (CCL4, TNF-α, IL-6), neutrophil activation (CXCL2, IL-8), T cell activation (CD40 ligand, IL-2, IL-12p70, IL-15), type 2 inflammation (eotaxin, IL-4, IL-13), type 17 inflammation (IL-17A), dendritic maturation (FLT3 ligand, IL-7), and counterregulatory molecules (PD-L1, IL-1 receptor antagonist, IL-10) in preBOS patients compared to transient impairment. These differences waned over time. In conclusion, a transient multifaceted nasal inflammatory response is associated with preBOS. Our findings require validation in larger longitudinal cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Division of Clinical Informatics, Liberty University College of Osteopathic Medicine, Lynchburg, VA.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
ORCID-Profile: Ehsan Irajizad, Liang Li, Lara Bashoura, Gabriela Rondon, Sophie Paczesny, Richard E Champlin, Burton F Dickey, Ajay Sheshadri
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Ostrin, E. J., Rider, N. L., Alousi, A. M., Irajizad, E., Li, L., Peng, Q., Kim, S. T., Bashoura, L., Arain, M. H., Noor, L. Z., Patel, N., Mehta, R., Popat, U. R., Hosing, C., Jenq, R. R., Rondon, G., Hanash, S. M., Paczesny, S., Shpall, E. J., …, & Sheshadri, A. (2023). A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2300031
Vancouver
Ostrin EJ, Rider NL, Alousi AM, Irajizad E, Li L, Peng Q, et al. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. ImmunoHorizons. 2023. doi:10.4049/immunohorizons.2300031
BibTeX
@article{Ostrin2023,
author = {Ostrin, Edwin J and Rider, Nicholas L and Alousi, Amin M and Irajizad, Ehsan and Li, Liang and Peng, Qian and Kim, Sang T and Bashoura, Lara and Arain, Muhammad H and Noor, Laila Z and Patel, Nikul and Mehta, Rohtesh and Popat, Uday R and Hosing, Chitra and Jenq, Robert R and Rondon, Gabriela and Hanash, Samir M and Paczesny, Sophie and Shpall, Elizabeth J and Champlin, Richard E and Dickey, Burton F and Sheshadri, Ajay},
title = {A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept},
journal = {ImmunoHorizons},
year = {2023},
doi = {10.4049/immunohorizons.2300031}
}
EUVIMED